440 related articles for article (PubMed ID: 22728083)
1. Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice.
Schäfer B; Piliponsky AM; Oka T; Song CH; Gerard NP; Gerard C; Tsai M; Kalesnikoff J; Galli SJ
J Allergy Clin Immunol; 2013 Feb; 131(2):541-8.e1-9. PubMed ID: 22728083
[TBL] [Abstract][Full Text] [Related]
2. Targeting C3a/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice.
Zhang Y; Yan X; Zhao T; Xu Q; Peng Q; Hu R; Quan S; Zhou Y; Xing G
Clin Exp Immunol; 2017 Jul; 189(1):60-70. PubMed ID: 28295247
[TBL] [Abstract][Full Text] [Related]
3. Mast cell activation is characterized by upregulation of a functional anaphylatoxin C5a receptor.
Soruri A; Grigat J; Kiafard Z; Zwirner J
BMC Immunol; 2008 Jun; 9():29. PubMed ID: 18559098
[TBL] [Abstract][Full Text] [Related]
4. Immune cell-derived C3a and C5a costimulate human T cell alloimmunity.
Cravedi P; Leventhal J; Lakhani P; Ward SC; Donovan MJ; Heeger PS
Am J Transplant; 2013 Oct; 13(10):2530-9. PubMed ID: 24033923
[TBL] [Abstract][Full Text] [Related]
5. Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a.
Gutzmer R; Köther B; Zwirner J; Dijkstra D; Purwar R; Wittmann M; Werfel T
J Invest Dermatol; 2006 Nov; 126(11):2422-9. PubMed ID: 16778800
[TBL] [Abstract][Full Text] [Related]
6. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma.
Drouin SM; Kildsgaard J; Haviland J; Zabner J; Jia HP; McCray PB; Tack BF; Wetsel RA
J Immunol; 2001 Feb; 166(3):2025-32. PubMed ID: 11160252
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-33 Amplifies Human Mast Cell Activities Induced by Complement Anaphylatoxins.
West PW; Bahri R; Garcia-Rodriguez KM; Sweetland G; Wileman G; Shah R; Montero A; Rapley L; Bulfone-Paus S
Front Immunol; 2020; 11():615236. PubMed ID: 33597949
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Anaphylatoxin Receptor Expression and C3a/C5a Functions in Anaphylatoxin Receptor Reporter Mice.
Laumonnier Y; Karsten CM; Köhl G; Köhl J
Curr Protoc Immunol; 2020 Sep; 130(1):e100. PubMed ID: 32710701
[TBL] [Abstract][Full Text] [Related]
9. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.
Gu H; Fisher AJ; Mickler EA; Duerson F; Cummings OW; Peters-Golden M; Twigg HL; Woodruff TM; Wilkes DS; Vittal R
FASEB J; 2016 Jun; 30(6):2336-50. PubMed ID: 26956419
[TBL] [Abstract][Full Text] [Related]
10. Detection of anaphylatoxin receptors on CD83+ dendritic cells derived from human skin.
Kirchhoff K; Weinmann O; Zwirner J; Begemann G; Götze O; Kapp A; Werfel T
Immunology; 2001 Jun; 103(2):210-7. PubMed ID: 11412308
[TBL] [Abstract][Full Text] [Related]
11. Chimeric receptors of the human C3a receptor and C5a receptor (CD88).
Crass T; Ames RS; Sarau HM; Tornetta MA; Foley JJ; Köhl J; Klos A; Bautsch W
J Biol Chem; 1999 Mar; 274(13):8367-70. PubMed ID: 10085065
[TBL] [Abstract][Full Text] [Related]
12. C3a, C5a renal expression and their receptors are correlated to severity of IgA nephropathy.
Liu L; Zhang Y; Duan X; Peng Q; Liu Q; Zhou Y; Quan S; Xing G
J Clin Immunol; 2014 Feb; 34(2):224-32. PubMed ID: 24327134
[TBL] [Abstract][Full Text] [Related]
13. In response to complement anaphylatoxin peptides C3a and C5a, human vascular endothelial cells migrate and mediate the activation of B-cells and polarization of T-cells.
Shivshankar P; Li YD; Mueller-Ortiz SL; Wetsel RA
FASEB J; 2020 Jun; 34(6):7540-7560. PubMed ID: 32301538
[TBL] [Abstract][Full Text] [Related]
14. Absence of signaling into CD4⁺ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3⁺ regulatory T cells.
Strainic MG; Shevach EM; An F; Lin F; Medof ME
Nat Immunol; 2013 Feb; 14(2):162-71. PubMed ID: 23263555
[TBL] [Abstract][Full Text] [Related]
15. Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse.
Van Beek J; Bernaudin M; Petit E; Gasque P; Nouvelot A; MacKenzie ET; Fontaine M
Exp Neurol; 2000 Jan; 161(1):373-82. PubMed ID: 10683302
[TBL] [Abstract][Full Text] [Related]
16. Complement peptides and mast cell triggering.
Erdei A; Pecht I
Immunol Lett; 1996 Dec; 54(2-3):109-12. PubMed ID: 9052863
[TBL] [Abstract][Full Text] [Related]
17. Airway smooth muscle cells enhance C3a-induced mast cell degranulation following cell-cell contact.
Thangam EB; Venkatesha RT; Zaidi AK; Jordan-Sciutto KL; Goncharov DA; Krymskaya VP; Amrani Y; Panettieri RA; Ali H
FASEB J; 2005 May; 19(7):798-800. PubMed ID: 15758041
[TBL] [Abstract][Full Text] [Related]
18. The human mast cell line HMC-1 expresses C5a receptors and responds to C5a but not to C5a(desArg).
Werfel T; Oppermann M; Butterfield JH; Begemann G; Elsner J; Götze O; Zwirner J
Scand J Immunol; 1996 Jul; 44(1):30-6. PubMed ID: 8693289
[TBL] [Abstract][Full Text] [Related]
19. Regulation of human mast cell and basophil function by anaphylatoxins C3a and C5a.
Ali H
Immunol Lett; 2010 Jan; 128(1):36-45. PubMed ID: 19895849
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells.
Takabayashi T; Shimizu S; Clark BD; Beinborn M; Burke JF; Gelfand JA
Surgery; 2004 May; 135(5):544-54. PubMed ID: 15118592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
